News | February 13, 2026
Merck’s KEYTRUDA bags FDA nod for platinum-resistant ovarian cancer
KEYTRUDA QLEX is contraindicated in patients with known hypersensitivity to its components
KEYTRUDA QLEX is contraindicated in patients with known hypersensitivity to its components
Waskyra is an ex vivo gene therapy that uses patients’ own CD34+ hematopoietic stem and progenitor cells, genetically engineered with a lentiviral vector
This is the first controlled pharmacologic study to demonstrate that treatment of obesity improved PsA disease measures
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
The move strengthens GBL’s clinical-stage presence in the United States
India has deep strengths in reverse engineering and API development, while Russia has strong capabilities in certain vaccines, biologicals, and niche therapeutic segments. Collaboration can significantly shorten R&D timelines
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Sepsis is a life-threatening reaction to infection that overwhelms the body’s defenses
Hyaluronic acid is among the world's most valuable biopolymers, with applications spanning from dermal fillers and wound healing to drug delivery and tissue engineering
Subscribe To Our Newsletter & Stay Updated
